首页 › 基金 › Parametrica Management Ltd › FATE
Parametrica Management Ltd 对 FATE 的持仓历史
FATE THERAPEUTICS INC · 医疗保健
Parametrica Management Ltd 在 Q3 2026 的 13F 申报中披露持有 FATE(FATE THERAPEUTICS INC)18,472 股,市值约 US$44K,约占其申报组合的 0.04%,在其申报持仓中市值排名第 26 位。 Parametrica Management Ltd 最近 13 个申报季度中有 13 个季度披露了 FATE 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Parametrica Management Ltd 对 FATE 的持仓演变
Parametrica Management Ltd 于 Q3 2023 首次披露 FATE 持仓:18,472 股(约 US$39K)。 该持仓在 Q1 2024 达到峰值 18,472 股,市值约 US$136K。 在 13 次申报中,Parametrica Management Ltd 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 18,472 股、市值约 US$44K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 18.47K | $39.16K | 新进 |
| Q4 2023 | 18.47K | $69.08K | 持有 |
| Q1 2024 | 18.47K | $135.58K | 持有 |
| Q2 2024 | 18.47K | $60.59K | 持有 |
| Q3 2024 | 18.47K | $64.65K | 持有 |
| Q4 2024 | 18.47K | $30.48K | 持有 |
| Q1 2025 | 18.47K | $14.60K | 持有 |
| Q2 2025 | 18.47K | $20.69K | 持有 |
| Q3 2025 | 18.47K | $23.27K | 持有 |
| Q4 2025 | 18.47K | $18.15K | 持有 |
| Q1 2026 | 18.47K | $22.17K | 持有 |
| Q2 2026 | 18.47K | $49.87K | 持有 |
| Q3 2026 | 18.47K | $43.78K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 FATE 与 13F 数据
FATE(FATE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 FATE,申报仓位最大的包括:Redmile Group, LLC (US$34.8M), JOHNSON & JOHNSON (US$8.0M), Bruce & Co., Inc. (US$2.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 FATE 的基金
- Redmile Group, LLC 12.87M 股 · $34.76M · Q2 2026
- JOHNSON & JOHNSON 3.38M 股 · $8.01M · Q3 2026
- Bruce & Co., Inc. 989.19K 股 · $2.67M · Q2 2026
更多关于 Parametrica Management Ltd
常见问题
How long has Parametrica Management Ltd held FATE?
Parametrica Management Ltd has disclosed FATE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parametrica Management Ltd's current position in FATE?
As of Q3 2026, Parametrica Management Ltd holds 18.47K shares of FATE (FATE THERAPEUTICS INC), valued at $43.78K, representing 0.04% of its reported portfolio and ranking #26.
Has Parametrica Management Ltd been buying or selling FATE?
In the latest 13F filing (Q3 2026), Parametrica Management Ltd held unchanged its position in FATE. The position peaked in Q1 2024 at 18.47K shares.
Which other funds hold FATE?
Other major institutional holders of FATE include Redmile Group, LLC, JOHNSON & JOHNSON, Bruce & Co., Inc., among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.